Skip to main content
Figure 2 | Journal of Translational Medicine

Figure 2

From: Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer

Figure 2

DC phenotype is conserved after transduction with AdCCL21. DC (A), and CCL21-DC (B), were analyzed for expression of the following surface markers: CD40, CD54, CD80, CD83, CD86, HLA-DR and CCR7, as indicated. Histograms show the expression of each surface molecule individually. White lines contour the isotype control. The percentage of positive cells and MFI are indicated. A representative experiment of at least three is shown.

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us